Pharmacodynamics(PD) study of Arbekacin Sulfate in Epithelial Lining Fluid (ELF), an open-label study.
Not Applicable
- Conditions
- Healthy volunteer
- Registration Number
- JPRN-UMIN000007162
- Lead Sponsor
- Keio University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1) History of hypersensitivity caused by aminoglycoside antibiotics or bacitracin. 2) One who has family or patient's history of hearing loss caused by aminoglycoside antibiotics. One who has hearing loss caused by any other reasons. 3)In medication. 4)Creatinine clearance and less than 30mL/min. 5)Smorker. 6)Any other participants whose condition is inappropriate for the evaluation of this clinical study, judged by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method